BIO-TECHNE Corp — Director's Dealing 2024

Aug 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-08-15

Reporting Person: Kelderman Kim (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-15	Performance Restricted Stock Units	$	A	51261	Acquired		Common Stock (51261)	Direct
2024-08-15	Restricted Stock Units	$	A	25630	Acquired		Common Stock (25630)	Direct
2024-08-15	Stock Options (Right to Buy)	$74.91	A	69061	Acquired	2034-08-15	Common Stock (69061)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	39942	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$37.70	2025-05-01	Common Stock (13392)	13392	Direct
Stock Option (Right to Buy)	$44.33	2025-08-08	Common Stock (84308)	84308	Direct
Stock Option (Right to Buy)	$47.60	2026-08-07	Common Stock (109536)	109536	Direct
Stock Option (Right to Buy)	$66.97	2027-08-05	Common Stock (117216)	117216	Direct
Stock Option (Right to Buy)	$120.46	2028-08-06	Common Stock (25944)	25944	Direct
Performance Restricted Stock Units	$		Common Stock (6984)	6984	Direct
Performance Stock Options (Right to Buy)	$94.52	2029-08-15	Common Stock (21704)	21704	Direct
Stock Options (Right to Buy)	$94.52	2029-08-15	Common Stock (28940)	28940	Direct
Performance Restricted Stock Units	$		Common Stock (8873)	8873	Direct
Performance Stock Options (Right to Buy)	$84.61	2030-08-15	Common Stock (23881)	23881	Direct
Stock Options (Right to Buy)	$84.61	2030-08-15	Common Stock (29391)	29391	Direct
Stock Options (Right to Buy)	$52.83	2030-11-01	Common Stock (38252)	38252	Direct
Performance Restricted Stock Units	$		Common Stock (9423)	9423	Direct
Performance Stock Options (Right to Buy)	$68.54	2031-02-01	Common Stock (25945)	25945	Direct
Stock Options (Right to Buy)	$68.54	2031-02-01	Common Stock (51890)	51890	Direct

Footnotes

F1: Fully exercisable.

F2: Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F4: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F5: Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.

F6: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F7: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.

F8: Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.

F9: Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.

F10: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F11: 8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.

F12: Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.